Trial by Dutch laboratories for evaluation of non-invasive prenatal testing. Part II—women's perspectives

Prenatal Diagnosis

Volumn 36, Issue 12, 2016, Pages 1091-1098

  van Schendel, Rachèl V ^a   Page Christiaens, G C Lieve ^b   Beulen, Lean ^c   Bilardo, Catia M ^d   de Boer, Marjon A ^a   Coumans, Audrey B C ^e   Faas, Brigitte H ^c   van Langen, Irene M ^d   Lichtenbelt, Klaske D ^b   van Maarle, Merel C ^f   Macville, Merryn V E ^e   Oepkes, Dick ^g   Pajkrt, Eva ^f   Henneman, Lidewij ^a  

^a VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^b UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^c RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^d UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^e MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

^f ACADEMIC MEDICAL CENTER   (Netherlands)

^g LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AMNIOCENTESIS; ANEUPLOIDY; ANXIETY; ARTICLE; ATTITUDE ASSESSMENT; CHORION VILLUS SAMPLING; CLINICAL EVALUATION; CONFLICT; CONTROLLED STUDY; DIAGNOSTIC TEST ACCURACY STUDY; DOWN SYNDROME; EDUCATIONAL STATUS; FEMALE; FIRST TRIMESTER PREGNANCY; HEALTH LITERACY; HIGH RISK PREGNANCY; HUMAN; INFORMATION DISSEMINATION; KNOWLEDGE; MAJOR CLINICAL STUDY; MEDICAL HISTORY; MULTIDIMENSIONAL MEASURE OF INFORMED CHOICE; NON INVASIVE PRENATAL TESTING; NON INVASIVE PROCEDURE; PATIENT COUNSELING; PATIENT DECISION MAKING; PATIENT EDUCATION; PATIENT PARTICIPATION; PATIENT PREFERENCE; PATIENT SAFETY; PREGNANCY TERMINATION; PREGNANT WOMAN; PRENATAL DIAGNOSIS; PRENATAL SCREENING; PRIORITY JOURNAL; TRISOMY 13; TRISOMY 18; TRISOMY 21; ATTITUDE TO HEALTH; BLOOD; CHROMOSOME 13; CHROMOSOME 18; CHROMOSOME DISORDER; DECISION MAKING; DNA SEQUENCE; EDWARDS SYNDROME; FALSE POSITIVE RESULT; FOLLOW UP; MIDDLE AGED; NETHERLANDS; PREGNANCY; PROCEDURES; PSYCHOLOGY; QUESTIONNAIRE; TIME FACTOR; TRISOMY; YOUNG ADULT;

DNA;

ADULT; ANXIETY; ATTITUDE TO HEALTH; CHROMOSOME DISORDERS; CHROMOSOMES, HUMAN, PAIR 13; CHROMOSOMES, HUMAN, PAIR 18; CONFLICT (PSYCHOLOGY); DECISION MAKING; DNA; DOWN SYNDROME; EDUCATIONAL STATUS; FALSE POSITIVE REACTIONS; FEMALE; FOLLOW-UP STUDIES; HEALTH LITERACY; HUMANS; MIDDLE AGED; NETHERLANDS; PREGNANCY; PREGNANCY TRIMESTER, FIRST; SEQUENCE ANALYSIS, DNA; SURVEYS AND QUESTIONNAIRES; TIME FACTORS; TRISOMY; TRISOMY 13 SYNDROME; TRISOMY 18 SYNDROME; YOUNG ADULT;

EID: 85003518585     PISSN: 01973851     EISSN: 10970223     Source Type: Journal    
DOI: 10.1002/pd.4941     Document Type: Article

References (35)

1. Allyse M, Minear MA, Berson E, et al. Non-invasive prenatal testing: a review of international implementation and challenges. Int J Womens Health 2015;7:113–26.
2. Gil MM, Quezada MS, Revello R, et al. Analysis of cell-free DNA in maternal blood in screening for fetal aneuploidies: updated meta-analysis. Ultrasound Obstet Gynecol 2015;45:249–66.
3. Norton ME, Jacobsson B, Swamy GK, et al. Cell-free DNA analysis for noninvasive examination of trisomy. N Engl J Med 2015;372:1589–97.
4. Warsof SL, Larion S, Abuhamad AZ. Overview of the impact of noninvasive prenatal testing on diagnostic procedures. Prenat Diagn 2015;35:972–9.
5. deJong A, Dondorp WJ, deDie-Smulders CEM, et al. Non-invasive prenatal testing: ethical issues explored. Eur J Hum Genet 2010;18:272–7.
6. vanSchendel RV, Kleinveld JH, Dondorp WJ, et al. Attitudes of pregnant women and male partners towards non-invasive prenatal testing and widening the scope of prenatal screening. Eur J Hum Genet 2014;22:1345–50.
7. Lewis C, Silcock C, Chitty LS. Non-invasive prenatal testing for Down's Syndrome: pregnant women's views and likely uptake. Public Health Genomics 2013;16:223–32.
8. Tamminga S, vanSchendel RV, Rommers W, et al. Changing to NIPT as a first-tier screening test and future perspectives: opinions of health professionals. Prenat Diagn 2015;35:1316–23.
9. Dondorp W, deWert G, Bombard Y, et al. Non-invasive prenatal testing for aneuploidy and beyond: challenges of responsible innovation in prenatal screening. Eur J Hum Genet 2015;23:1438–50.
10. Marteau TM, Dormandy E, Michie S. A measure of informed choice. Health Expect 2001;4:99–108.
11. Michie S, Dormandy E, Marteau TM. The multi-dimensional measure of informed choice: a validation study. Patient Educ Couns 2002;48:87–91.
12. van denBerg M, Timmermans DRM, tenKate LP, et al. Are pregnant women making informed choices about prenatal screening? Genet Med 2005;7:332–8.r
13. Sachs A, Blanchard L, Buchanan A, Bianchi DW. Recommended pre-test counseling points for noninvasive prenatal testing using cell-free DNA: a 2015 perspective. Prenat Diagn 2015;35:968–71.
14. Atsma F, Jansen B, Liefers J. Monitor 2013 screeningsprogramma downsyndroom en structureel echoscopisch onderzoek. Nijmegen: Radboudumc/Scientific Institute for Quality of Healthcare; 2014.
15. Oepkes D, Page-Christiaens LC, Bax CJ, et al. Trial by Dutch laboratories for evaluation of Non-Invasive Prenatal Testing. Part I - clinical impact. Prenat Diagn 2016, DOI: 10.1002/pd.4945.
16. O'Connor AM. Validation of a Decisional Conflict Scale. Medical Decision Making 1995;15:25–30.
17. Koedoot N, Molenaar S, Oosterveld P, et al. The decisional conflict scale: further validation in two samples of Dutch oncology patients. Patient Educ Couns 2001;45:187–93.
18. Marteau TM, Bekker H. The development of a six-item short-form of the state scale of the Spielberger State-Trait Anxiety Inventory (STAI). Br J Clin Psychol 1992;31:301–6.
19. van derBij AK, deWeerd S, Cikot RJLM, et al. Validation of the Dutch Short Form of the State Scale of the Spielberger State-Trait Anxiety Inventory: considerations for usage in screening outcomes. Publ Health Genomics 2003;6:84–7.
20. Chew L, Bradley K, Boyko E. Brief questions to identify patients with inadequate health literacy. Fam Med 2004;36:588–94.
21. Fransen MP, Van Schaik TM, Twickler TB, Essink-Bot ML. Applicability of internationally available health literacy measures in the Netherlands. J Health Commun 2011;16:134–49.
22. Lewis C, Hill M, Skirton H, Chitty LS. Development and validation of a measure of informed choice for women undergoing non-invasive prenatal testing for aneuploidy. Eur J Hum Genet 2016;24:809–16.
23. Statistics Netherlands [WWW document]. URL http://www.cbs.nl/nl-NL/menu/home/default.htm. [Accessed on 1 December 2015].
24. vanSchendel RV, Dondorp WJ, Timmermans DR, et al. NIPT-based screening for Down syndrome and beyond: what do pregnant women think? Prenat Diagn 2015;35:598–604.
25. Verweij EJ, Oepkes D, deBoer MA. Changing attitudes towards termination of pregnancy for trisomy 21 with non-invasive prenatal trisomy testing: a population-based study in Dutch pregnant women. Prenat Diagn 2013;33:397–9.
26. Chitty LS, Wright D, Hill M, et al. Uptake, outcomes, and costs of implementing non-invasive prenatal testing for Down's syndrome into NHS maternity care: prospective cohort study in eight diverse maternity units. BMJ 2016;354:i3426.
27. Taylor J, Chock V, Hudgins L. NIPT in a clinical setting: an analysis of uptake in the first months of clinical availability. J Genet Counsel 2014;23:72–8.
28. Rowe HJ, Fisher JRW, Quinlivan JA. Are pregnant Australian women well informed about prenatal genetic screening? A systematic investigation using the Multidimensional Measure of Informed Choice. Austr NZ J Obstet Gyn 2006;46:433–9.
29. Kuppermann M, Pena S, Bishop JT, et al. Effect of enhanced information, values clarification, and removal of financial barriers on use of prenatal genetic testing: a randomized clinical trial. JAMA 2014;312:1210–7.
30. Beulen L, Van den Berg M, Faas BH, et al. The effect of a decision aid on informed decision making in the era of non-invasive prenatal testing: a randomized controlled trial. Eur J Hum Genet 2016;24:1409–16.
31. Bjorklund U, Marsk A, Levin C, Ohman SG. Audiovisual information affects informed choice and experience of information in antenatal Down syndrome screening—a randomized controlled trial. Patient Educ Couns 2012;86:390–5.
32. Farrell R, Hawkins A, Barragan D, et al. Knowledge, understanding, and uptake of noninvasive prenatal testing among Latina women. Prenat Diagn 2015;35:748–53.
33. Fransen MP, Essink-Bot ML, Vogel I, et al. Ethnic differences in informed decision-making about prenatal screening for Down's syndrome. J Epid Community Health 2010;64:262–8.
34. Ames AG, Metcalfe SA, Archibald AD, et al. Measuring informed choice in population-based reproductive genetic screening: a systematic review. Eur J Hum Genet 2015;23:8–21.
35. Gitsels-van der Wal J, Verhoeven PS, Mannien J, et al. Factors affecting the uptake of prenatal screening tests for congenital anomalies; a multicentre prospective cohort study. BMC Pregn Childbirth 2014;14:1–12.